financetom
Business
financetom
/
Business
/
National Bank on Maple Leaf Foods 2025 Outlook
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
National Bank on Maple Leaf Foods 2025 Outlook
Jan 13, 2025 11:41 AM

02:00 PM EST, 01/13/2025 (MT Newswires) -- National Bank has kept its $26 target and Outperform rating on Maple Leaf Foods ( MLFNF ) after the company released its 2025 outlook.

Key takeaways:

Maple Leaf Foods ( MLFNF ) expects 2025 sales growth in the mid-single digits (NBF models 3% y/y vs. cons. at 4% y/y) and EBITDA of at least $634 million (NBF is $639 million vs. cons. at $642 million).

The company could also evaluate share repurchases as management views its equity to be below intrinsic value. National Bank does not model 2025 NCIB.

Maple Leaf Foods ( MLFNF ) also raised its quarterly dividend by 9% to $0.24 from $0.22, and eliminated the dividend reinvestment plan.

Price: 21.53, Change: -0.28, Percent Change: -1.28

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Ecolab Q2 Adjusted Earnings, Revenue Increase; Adjusts 2024 EPS Outlook
Ecolab Q2 Adjusted Earnings, Revenue Increase; Adjusts 2024 EPS Outlook
Jul 30, 2024
08:46 AM EDT, 07/30/2024 (MT Newswires) -- Ecolab ( ECL ) reported Q2 adjusted earnings Tuesday of $1.68 per diluted share, up from $1.24 a year earlier. Analysts polled by Capital IQ expected $1.67. Revenue for the quarter ended June 30 was $3.99 billion compared with $3.85 billion a year earlier. Analysts surveyed by Capital IQ expected $4.03 billion. For...
SITE Centers Q2 Operating Funds From Operations, Revenue Fall
SITE Centers Q2 Operating Funds From Operations, Revenue Fall
Jul 30, 2024
08:48 AM EDT, 07/30/2024 (MT Newswires) -- SITE Centers ( SITC ) reported Q2 operating funds from operations Tuesday of $0.27 per diluted share, down from $0.29 a year earlier. Analysts polled by Capital IQ expected $0.24. Revenue for the quarter ended June 30 was $114.1 million, down from $136.4 million a year earlier. Analysts surveyed by Capital IQ expected...
Merck's Q2 Earnings: Revenue And EPS Beat Helped By Strong Keytruda Sales, But Acquisition Costs Bites Into Annual Profit Forecast
Merck's Q2 Earnings: Revenue And EPS Beat Helped By Strong Keytruda Sales, But Acquisition Costs Bites Into Annual Profit Forecast
Jul 30, 2024
On Tuesday, Merck & Co Inc  reported second-quarter sales of $16.1 billion, up 7% year-over-year, beating the consensus estimate of $15.84 billion. Excluding the impact of foreign exchange, sales increased 11%. Merck ( MRK ) reported adjusted EPS of $2.28, a shift from an EPS loss of $(2.06), beating the consensus of $2.15. The pharmaceutical unit booked $14.41 billion in revenue, up 7% year over...
BGC Group's Q2 Adjusted Earnings, Revenue Rise; Q3 Guidance Issued
BGC Group's Q2 Adjusted Earnings, Revenue Rise; Q3 Guidance Issued
Jul 30, 2024
08:45 AM EDT, 07/30/2024 (MT Newswires) -- BGC Group ( BGC ) reported Q2 adjusted earnings Tuesday of $0.23 per share, up from $0.20 a year earlier. A single analyst polled by Capital IQ expected $0.23. Revenue for the quarter ended June 30 was $550.8 million, up from $493.1 million a year earlier. A single analyst surveyed by Capital IQ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved